-
[文献書誌] Kumada M et al.: "Association of hypoadiponectinemia with coronary artery disease in men"Arterioscler Thromb Vasc Biol.. 23. 85-89 (2003)
-
[文献書誌] Adamczak M et al.: "Decreased plasma adiponectin concentration in patients with essential hypertension"Am J Hypertens. 16. 72-75 (2003)
-
[文献書誌] Nemet D et al.: "Adipocytokines, body composition, and fitness in children"Pediatr Res.. 53. 148-152 (2003)
-
[文献書誌] Mallamaci F et al.: "Adiponectin in essential hypertension"J Nephrol. 15. 507-511 (2002)
-
[文献書誌] Okamoto Y et al.: "Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice"Circulation. 106. 2767-2770 (2002)
-
[文献書誌] Yang WS et al.: "Plasma adiponectin levels in overweight and obese Asians"Obes Res. 10. 1104-1110 (2002)
-
[文献書誌] Stefan N et al.: "Plasma adiponectin levels are not associated with fat oxidation in humans"Obes Res. 10. 1016-1020 (2002)
-
[文献書誌] Stefan N et al.: "Plasma adiponectin concentrations in children : relationships with obesity and insulinemia"J Clin Endocrinol Metab.. 67. 4652-4656 (2002)
-
[文献書誌] Vozarova B et al.: "Low plasma adiponectin concentrations do not predict weight gain in humans"Diabetes. 51. 2964-2967 (2002)
-
[文献書誌] Kuriyama H et al.: "Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9"Diabetes. 51. 2915-2921 (2002)
-
[文献書誌] Nishizawa H et al.: "Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein"Diabetes. 51. 2734-2741 (2002)
-
[文献書誌] Imagawa A et al.: "Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes"Diabetes Care. 25. 1665-1666 (2002)
-
[文献書誌] Delporte ML et al.: "Pre-and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion : in vitro and in vivo studies"Biochem J.. 367. 677-685 (2002)
-
[文献書誌] Matsuda M et al.: "Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis"J Biol Chem.. 277. 37487-37491 (2002)
-
[文献書誌] Lindsay RS et al.: "Adiponectin and development of type 2 diabetes in the Pima Indian population"Lancet. 360. 57-58 (2002)
-
[文献書誌] Kondo H et al.: "Association of adiponectin mutation with type 2 diabetes : a candidate gene for the insulin resistance syndrome"Diabetes. 51. 2325-2358 (2002)
-
[文献書誌] Arita Y et al.: "Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell"Circulation. 105. 2893-2898 (2002)
-
[文献書誌] Maeda N et al.: "Diet-induced insulin resistance in mice lacking adiponectin/ACRP30"Nat Med.. 8. 731-737 (2002)
-
[文献書誌] Stefan N et al.: "Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans"Diabetes. 51. 1884-1888 (2002)
-
[文献書誌] Yokota T et al.: "Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins"J Clin Invest. 109. 1303-1310 (2002)
-
[文献書誌] Kondo H et al.: "Human aquaporin adipose(AQPap)gene. Genomic structure, promoter analysis and functional mutation"Eur J Biochem.. 269. 1814-1826 (2002)
-
[文献書誌] Matsumoto S et al.: "Increased plasma HB-EGF associated with obesity and coronary artery disease"Biochem Biophys Res Commun. 292. 781-786 (2002)
-
[文献書誌] Yang WS et al.: "Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients"Diabetes Care. 25. 376-380 (2002)
-
[文献書誌] Nagaretani H et al.: "Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance"Diabetes Care. 24. 2127-2133 (2002)
-
[文献書誌] Nishizawa H: "Small heterodimer partner, an orphan nuclear receptor, augments PPARg transactivation"J Biol Chem. 277. 1586-1592 (2002)
-
[文献書誌] Zoccali C et al.: "Adiponectin, the most abundant adipocyte-derived protein, is functionally related to metabolic risk factors and predicts cardiovascular outcomes in end stage renal disease"J Am Soc Nephrol. 109. 134-141 (2002)